
Opinion|Videos|July 30, 2026
Medication Access, Financial Navigation, and Care Transitions
In this episode, Ali tackles the operational barriers that prevent patients from starting menin inhibitors despite being approved.
Advertisement
Episodes in this series

In this episode, Ali tackles the operational barriers that prevent patients from starting menin inhibitors despite being approved. He shares strategies for prior authorization success, timely manufacturer hub enrollment, insurance-driven copay navigation, and adherence escalation protocols—plus reveals the most common gaps when patients transition from academic centers to community pharmacy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
What Does the FDA Advisory Committee’s Vote on 7 Peptides Mean for Pharmacy Practice?
2
Beyond Off-Label: How Auvelity's Approval Changes Agitation Management in Alzheimer Disease
3
Ensitrelvir Approved for Postexposure Prophylaxis of COVID-19
4
GLP-1s May Curb Lung Fibrosis in Diabetes, Long COVID
5







































































































